1,511
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Maternal serum nitrotyrosine, 8-isoprostane and total antioxidant capacity levels in pre-gestational or gestational diabetes mellitus

ORCID Icon, , &
Pages 36-42 | Received 07 Jul 2020, Accepted 26 Aug 2020, Published online: 11 Dec 2020

References

  • Toescu V, Nuttall SL, Martin U, et al. Changes in plasma lipids and markers of oxidative stress in normal pregnancy and pregnancies complicated by diabetes. Clin Sci. 2004;106(1):93–98.
  • Lappas M, Permezel M, Rice GE. Release of proinflammatory cytokines and 8-isoprostane from placenta, adipose tissue, and skeletal muscle from normal pregnant women and women with gestational diabetes mellitus. J Clin Endocrinol Metab. 2004;89(11):5627–5633.
  • Horvath EM, Magenheim R, Kugler E, et al. Nitrative stress and poly(ADP-ribose) polymerase activation in healthy and gestational diabetic pregnancies. Diabetologia. 2009;52(9):1935–1943.
  • Răchişan AL, Hruşcă A, Căinap S, et al. The activity of 8-iso-prostaglandin F2alpha as an oxidative stress marker in vivo in paediatric patients with type 1 diabetes mellitus and associated autoimmunities. Clin Lab. 2014;60(2):253–259.
  • Ozler S, Oztas E, Uygur D, et al. The value of total antioxidant status and serum tumor necrosis factor-α levels at 24-28 weeks of gestation in the prediction of optimal treatment protocol in gestational diabetes mellitus. Exp Clin Endocrinol Diabetes. 2019;127(7):485–491.
  • Zamani-Ahari U, Zamani-Ahari S, Fardi-Azar Z, et al. Comparison of total antioxidant capacity of saliva in women with gestational diabetes mellitus and non-diabetic pregnant women. J Clin Exp Dent. 2017;9(11):e1282–e1286.
  • Coughlan MT, Vervaart PP, Permezel M, et al. Altered placental oxidative stress status in gestational diabetes mellitus. Placenta. 2004;25(1):78–84.
  • Shang M, Zhao J, Yang L, et al. Oxidative stress and antioxidant status in women with gestational diabetes mellitus diagnosed by IADPSG criteria. Diabetes research and clinical practice. 2015;109(2):404–410.
  • Li H, Yin Q, Li N, et al. Plasma markers of oxidative stress in patients with gestational diabetes mellitus in the second and third trimester. Obstet Gynecol Int. 2016;2016:3865454.
  • Rueangdetnarong H, Sekararithi R, Jaiwongkam T, et al. Comparisons of the oxidative stress biomarkers levels in gestational diabetes mellitus (GDM) and non-GDM among Thai population: cohort study. Endocr Connect. 2018;7(5):681–687.
  • Szabó C, Zanchi A, Komjáti K, et al. Poly(ADP-Ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity. Circulation. 2002;106(21):2680–2686.
  • Gelisgen R, Genc H, Kayali R, et al. Protein oxidation markers in women with and without gestational diabetes mellitus: a possible relation with paraoxonase activity. Diabetes Res Clin Pract. 2011;94(3):404–409.
  • Zygula A, Kosinski P, Zwierzchowska A, et al. Oxidative stress markers in saliva and plasma differ between diet-controlled and insulin-controlled gestational diabetes mellitus. Diabetes Res Clin Pract. 2019;148:72–80.
  • Usluogullari B, Usluogullari CA, Balkan F, et al. Role of serum levels of irisin and oxidative stress markers in pregnant women with and without gestational diabetes. Gynecol Endocrinol. 2017;33(5):405–407.
  • Surdacka A, Ciężka E, Pioruńska-Stolzmann M, et al. Relation of salivary antioxidant status and cytokine levels to clinical parameters of oral health in pregnant women with diabetes. Arch Oral Biol. 2011;56(5):428–436.